Skip to content
Studies have shown that active fund managers routinely underperform the S&P500 index*
Home
Articles
WALL STREET X
Forecasts
Portfolios
Wall Street X
Articles
Forecasts
Portfolios
Search
Results for
{phrase}
(
{results_count}
of
{results_count_total}
)
Displaying
{results_count}
results of
{results_count_total}
Castle Biosciences, Inc. (NASDAQ: CSTL)
CSTL Stock Predictions and Ratings
WSX Rating:
SELL
WSX Forecast (1yr):
-4.30%
Analyst Rating:
STRONG BUY
Analyst Forecast (1yr):
8.90%
CSTL Stock Analysis
CSTL
PE Ratio:
CSTL
PEG Ratio:
Not Available
CSTL
Forward EPS Growth (12 month):
0.00%
CSTL
PS Ratio:
1.8
CSTL
PSG Ratio:
Not Available
CSTL
Forward Revenue Growth (12 month):
0.00%
CSTL Articles
No data was found